- Cicletanine
-
Cicletanine Systematic (IUPAC) name 3-(4-Chlorophenyl)-6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol Clinical data AHFS/Drugs.com International Drug Names Pregnancy cat. ? Legal status ? Routes Oral Pharmacokinetic data Protein binding 97.3% Half-life 7.9 h Identifiers CAS number 89943-82-8 ATC code C03BX03 PubChem CID 54910 ChemSpider 49583 UNII CHG7QC509W KEGG D03487 ChEMBL CHEMBL191886 Chemical data Formula C14H12ClNO2 Mol. mass 261.703 g/mol SMILES eMolecules & PubChem (what is this?) (verify)
Cicletanine is a furopyridine low-ceiling diuretic drug, usually used in the treatment of hypertension.[1] The drug is manufactured by Ipsen and marketed by Recordati (in France) under the trade name Tenstaten.
It appears to be more potent in salt-sensitive hypertension.[2]
Mechanism
It can inhibit protein kinase C.[3]
References
- ^ Jean Sassard (1992). Genetic Hypertension. John Libbey Eurotext. ISBN 9780861963133. http://books.google.com/?id=v4E_g_D6xCwC&pg=PA547&lpg=PA547&dq=Cicletanine
- ^ Bagrov AY, Dmitrieva RI, Dorofeeva NA et al. (February 2000). "Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism". J. Hypertens. 18 (2): 209–15. doi:10.1097/00004872-200018020-00012. PMID 10694190. http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0263-6352&volume=18&issue=2&spage=209.
- ^ Fedorova OV, Talan MI, Agalakova NI, Droy-Lefaix MT, Lakatta EG, Bagrov AY (March 2003). "Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension". Hypertension 41 (3): 505–11. doi:10.1161/01.HYP.0000053446.43894.9F. PMID 12623951. http://hyper.ahajournals.org/cgi/pmidlookup?view=long&pmid=12623951.
External links
Antihypertensives: diuretics (C03) Sulfonamides
(except EA)CA inhibitors (at PT)Thiazide-likes (primarily DCT)Quinethazone • Clopamide • Chlortalidone • Mefruside • Clofenamide • Metolazone • Meticrane • Xipamide • Indapamide • Clorexolone • FenquizonePotassium-sparing (at CD) ESC blockersOsmotic diuretics (PT, DL) VAs (DCT and CD) vaptans: Conivaptan • Mozavaptan • Satavaptan • Tolvaptan
tetracyclines: DemeclocyclineOther mercurial diuretic (Mersalyl) • Theobromine • Cicletanine#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it.